Millions of Americans Decline Second Dose of Experimental mRNA COVID-19 Vaccines

Share this:

By the end of April 2021, about eight percent of those who received the first dose of the experimental mRNA Pfizer/BioNTech or Moderna/NIAID COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA) granted by the U.S. Food and Drug Administration (FDA) had not received the second dose of the vaccines. This represents more than five million people in the United States.1 The percentage of people who had missed the second COVID vaccine dose was up by 3.4 percent since March 2021.2

The Pfizer/BioNTech and Moderna/NIAID (National Institute of Allergy and Infectious Diseases) COVID-19 vaccines are supposed to be given in two doses three to four weeks apart.3

“Obviously whenever you have a two-dose vaccine, you’re going to see people who for one reason or other—convenience, forgetting, a number of other things—just don’t show up for the second vaccine,” said Anthony Fauci, MD, director of NIAID.4

Public health officials predicted that two-dose vaccination campaign for adults would be challenging. Officials say that childhood vaccines, which usually have multiple doses, are easier to administer because children are scheduled to see their pediatricians frequently for “well-child” visits.5

Why Some Americans Are Skipping the Second Dose of the COVID-19 Vaccine…

Read the full story here: Source: Millions of Americans Decline Second Dose of Experimental mRNA COVID-19 Vaccines – The Vaccine Reaction


Share this:
Scroll to Top